Terug
Dagbereik
€ 59,98
€ 63,39
52-Weeksbereik
€ 10,81
€ 94,57
Volume
242.172
50D / 200D Gem.
€ 75,51
/
€ 51,38
Vorige Slotkoers
€ 64,63
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,6 | 0,4 |
| P/B | 115,4 | 2,9 |
| ROE % | -197,9 | 3,9 |
| Net Margin % | -10773,5 | 3,8 |
| Rev Growth 5Y % | -34,6 | 10,0 |
| D/E | 13,4 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,75
€ 1,75 – € 1,75
|
190 M | 1 |
| FY2029 |
€ 0,22
€ 0,22 – € 0,22
|
130 M | 1 |
| FY2028 |
-€ 0,95
-€ 0,95 – -€ 0,95
|
98 M | 1 |
Belangrijkste Punten
Revenue declined -34,64% annually over 5 years
Earnings declined -108,30% over the past year
Debt/Equity of 13,39 — high leverage
Negative free cash flow of -129,83M
PEG of 0,08 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 584,64%
Groei
Revenue Growth (5Y)
-34,64%
Revenue (1Y)550,00%
Earnings (1Y)-108,30%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-197,85%
ROIC-88,06%
Net Margin-10773,46%
Op. Margin-10386,54%
Veiligheid
Debt / Equity
13,39
Current Ratio3,93
Interest Coverage-11,07
Waardering
P/E Ratio
-6,58
P/B Ratio115,35
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 550,00% | Revenue Growth (3Y) | -15,02% |
| Earnings Growth (1Y) | -108,30% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -34,64% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,30M | Net Income (TTM) | -140,06M |
| ROE | -197,85% | ROA | -95,62% |
| Gross Margin | -91,00% | Operating Margin | -10386,54% |
| Net Margin | -10773,46% | Free Cash Flow (TTM) | -129,83M |
| ROIC | -88,06% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 13,39 | Current Ratio | 3,93 |
| Interest Coverage | -11,07 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -6,58 | P/B Ratio | 115,35 |
| P/S Ratio | 709,23 | PEG Ratio | 0,08 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 922,00M | Enterprise Value | 904,79M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,30M | 200.000,0 | 1,80M | 2,19M | 7,13M |
| Net Income | -140,06M | 1,69B | -241,36M | -145,23M | -81,77M |
| EPS (Diluted) | -9,04 | 116,58 | -5,12 | -3,62 | -2,15 |
| Gross Profit | -1,18M | -2,09M | 609.000,0 | -107,99M | 4,44M |
| Operating Income | -135,03M | -331,45M | -219,22M | -129,12M | -76,56M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 146,48M | 180,77M | 307,89M | 290,88M | 150,45M |
| Total Liabilities | 138,49M | 47,18M | 264,39M | 232,82M | 98,07M |
| Shareholders' Equity | 7,99M | 133,58M | 43,50M | 58,06M | 52,38M |
| Total Debt | 107,01M | 8,05M | 210,14M | 207,10M | 72,14M |
| Cash & Equivalents | 124,22M | 152,60M | 277,92M | 273,87M | 131,30M |
| Current Assets | 132,83M | 160,40M | 295,36M | 280,49M | 139,11M |
| Current Liabilities | 33,80M | 40,73M | 56,31M | 27,58M | 22,45M |